Chang C T, Khan A J, Agbayani M M, Jhaveri R, Amin I, Evans H E
Antimicrob Agents Chemother. 1978 Dec;14(6):838-41. doi: 10.1128/AAC.14.6.838.
Cefamandole, a new cephalosporin antibiotic, has greater activity against common pathogens, including Escherichia coli, Haemophilus influenzae, and Proteus (including indole-positive strains), than available cephalosporin drugs. We have evaluated the safety and pharmacokinetics of this drug in 30 infants and children. Blood levels and urinary excretion of the drug were similar to those previously found in adults. The only side effects were mild and transient elevation of serum glutamic oxalacetic transaminase in 12 patients and of blood urea nitrogen in 1 patient in whom serum creatinine remained normal and unchanged.
头孢孟多,一种新型头孢菌素抗生素,对常见病原体,包括大肠杆菌、流感嗜血杆菌和变形杆菌(包括吲哚阳性菌株)的活性比现有头孢菌素药物更强。我们已在30名婴幼儿和儿童中对该药物的安全性和药代动力学进行了评估。该药物的血药浓度和尿排泄情况与先前在成人中发现的情况相似。仅有的副作用是12名患者血清谷草转氨酶轻度短暂升高,1名患者血尿素氮升高,而其血清肌酐保持正常且未发生变化。